Summary by Moomoo AI
On February 1, 2024, Timothy K Lu, CEO and President of Senti Biosciences, Inc. (SNTI), completed a significant stock transaction involving the company's common stock. Lu was granted 306,000 shares at no cost, as per the transaction details. Following this grant, Lu's direct holdings in Senti Biosciences increased to a total of 865,496 shares. Additionally, Lu has indirect beneficial ownership of 1,056,780 shares, which includes shares held by his spouse and others as detailed in the footnotes. The transaction reflects a substantial increase in Lu's stake in the company, emphasizing his vested interest in the company's success.